Amber Bahorik, PhD

TitlePostdoctoral Scholar
SchoolUCSF School of Medicine
Address530 Parnassus Ave
San Francisco CA 94143
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of PittsburghPhD2015Social Work
    University of California San FranciscoPostdoctoral Fellowship2015Psychiatry; Drug Abuse/Treatment Services and Research

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Bahorik A, Satre DD, Kline-Simon AH, Weisner CM, Young-Wolff KC, Campbell CI. Alcohol, Marijuana, and Opioid Use Disorders: 5-Year Patterns and Characteristics of Emergency Department Encounters. Subst Abus. 2017 Jul 19; 0. PMID: 28723312.
      View in: PubMed
    2. Bahorik A, Satre DD, Kline-Simon AH, Weisner CM, Campbell CI. . Serious mental illness and medical comorbidities: Findings from an integrated health care system. Psychosomatic Research. 2017; (100):35-45.
    3. Campbell CI, Bahorik A, Kline-Simon AH, Satre DD. The role of marijuana use disorder in predicting emergency department and inpatient encounters: A retrospective cohort study. Drug Alcohol Depend. 2017 Jun 10; 178:170-175. PMID: 28651153.
      View in: PubMed
    4. Ray GT, Bahorik A, Van Veldhuisen V, Weisner CM, Rubinstein AL, Campbell CI. Prescription opioid registry in an integrated health system. Am J Manag Care. 2017; 5(23):e146-e155.
    5. Bahorik A, Greeno CG, Cochran G, Cornelius JR, Eack SM. Motivation deficits and use of alcohol and illicit drugs among individuals with schizophrenia. Psychiatry Res. 2017 Apr 05; 253:391-397. PMID: 28441618.
      View in: PubMed
    6. Bahorik A, Leibowitz A, Sterling SA, Travis A, Weisner C, Satre DD. Patterns of marijuana use among psychiatry patients with depression and its impact on recovery. J Affect Disord. 2017 Feb 14; 213:168-171. PMID: 28242498.
      View in: PubMed
    7. Bahorik A, Satre DD, Kline-Simon AH, Weisner CM, Campbell CI, et al. Alcohol, Cannabis, and Opioid Use Disorders, and Disease Burden in an Integrated Health Care System. J Addict Med. 2016 Sep 8. PMID: 27610582.
      View in: PubMed
    8. Bahorik A, Leibowitz A, Sterling SA, Travis A, Weisner C, Satre DD, et al. The role of hazardous drinking reductions in predicting depression and anxiety symptom improvement among psychiatry patients: A longitudinal study. J Affect Disord. 2016 Jul 19; 206:169-173. PMID: 27475887.
      View in: PubMed
    9. Bahorik, AL, Queen CC, Chen S, Jackson Foster LJ, Bangs RL. Racial disparities in community outcomes among adults with schizophrenia and comorbid substance use disorders. J SocWork Prac Addict. 2014; 2(15):165-184.
    10. Eack SM, Hogarty SS, Greenwald DP, Bahorik A, Litschge MY, Bangalore SS, Pogue-Gelie MF, Cornelius JR. Integrated cognitive enhancement therapy and personal therapy for substance misusing schizophrenia patients: interim results on the first 6 months of treatment. Drug Alcohol Depend. 2014; (140):e53.
    11. Bahorik A, Cornelius JR, Bangalore SS, Newhill CE, Keshavan MS, Eack SM, et al. BRIEF REPORT: THE IMPACT OF ALCOHOL AND CANNABIS MISUSE ON COGNITION AMONG INDIVIDUALS WITH SCHIZOPHRENIA. Schizophr Res Cogn. 2014 Sep 1; 1(3):160-163. PMID: 25419516.
      View in: PubMed
    12. Bahorik A, Newhill CE, Queen CC, Eack SM. Letter to the editor: Critique of Bahorik et al. (2013)--'Underreporting of drug use among individuals with schizophrenia: prevalence and predictors'--a reply. Psychol Med. 2014 Feb; 44(3):670-1. PMID: 24524169.
      View in: PubMed
    13. Eack SM, Greenwald DP, Hogarty SS, Bahorik A, Litschge MY, Mazefsky CA, Minshew NJ. Cognitive enhancement therapy for adults with autism spectrum disorder: results of an 18-month feasibility study. J Autism Dev Disord. 2013 Dec; 43(12):2866-77. PMID: 23619953; PMCID: PMC3773526.
    14. Eack SM, Bahorik A, Hogarty SS, Greenwald DP, Litschge MY, Mazefsky CA, Minshew NJ. Brief report: is cognitive rehabilitation needed in verbal adults with autism? Insights from initial enrollment in a trial of cognitive enhancement therapy. J Autism Dev Disord. 2013 Sep; 43(9):2233-7. PMID: 23381484; PMCID: PMC3686872.
    15. Bahorik A, Newhill CE, Eack SM. Neurocognitive functioning of individuals with schizophrenia: using and not using drugs. Schizophr Bull. 2014 Jul; 40(4):856-67. PMID: 23884348; PMCID: PMC4059433.
    16. Eack SM, Bahorik A, McKnight SA, Hogarty SS, Greenwald DP, Newhill CE, Phillips ML, Keshavan MS, Minshew NJ. Commonalities in social and non-social cognitive impairments in adults with autism spectrum disorder and schizophrenia. Schizophr Res. 2013 Aug; 148(1-3):24-8. PMID: 23768814; PMCID: PMC3732579.
    17. Bahorik A, Newhill CE, Queen CC, Eack SM. Under-reporting of drug use among individuals with schizophrenia: prevalence and predictors. Psychol Med. 2014 Jan; 44(1):61-9. PMID: 23551851.
      View in: PubMed
    18. Bahorik A, Newhill CE, Eack SM. Characterizing the longitudinal patterns of substance use among individuals diagnosed with serious mental illness after psychiatric hospitalization. Addiction. 2013 Jul; 108(7):1259-69. PMID: 23432626; PMCID: PMC3679358.
    19. Eack SM, Bahorik A, Newhill CE, Neighbors HW, Davis LE. Interviewer-perceived honesty as a mediator of racial disparities in the diagnosis of schizophrenia. Psychiatr Serv. 2012 Sep 1; 63(9):875-80. PMID: 22751938; PMCID: PMC3718294.
    20. Bahorik A, Eack SM. Examining the course and outcome of individuals diagnosed with schizophrenia and comorbid borderline personality disorder. Schizophr Res. 2010 Dec; 124(1-3):29-35. PMID: 20888189.
      View in: PubMed
    Amber's Networks
    Derived automatically from this person's publications.
    People in Profiles who have published with this person.
    Related Authors
    People who share related concepts with this person.
    Back to TOP